Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study-Reference-Cited by-同舟云学术

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study

Published:2020-06-08 Issue:6 Volume:14 Page:e0008298
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Dubray Christine L.^ORCID,Sircar Anita D.,Beau de Rochars Valery Madsen,Bogus Joshua^ORCID,Direny Abdel N.,Ernest Jean Romuald,Fayette Carl R.,Goss Charles W.^ORCID,Hast Marisa^ORCID,O’Brian Kobie,Pavilus Guy Emmanuel,Sabin Daniel Frantz^ORCID,Wiegand Ryan E.,Weil Gary J.,Lemoine Jean Frantz

Funder

Bill and Melinda Gates Foundation

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference34 articles.

1. Neglected tropical diseases: diagnosis, clinical management, treatment and control;J Utzinger;Swiss medical weekly,2012

2. World Health Organization (1997). Elimination of lymphatic filariasis as a public health problem—resolution of the executive board of the WHO. Available from: http://www.who.int/neglected_diseases/mediacentre/WHA_50.29_Eng.pdf

3. World Health Organisation (2018). Global Programme to Eliminate Lymphatic Filariasis. Available from: http://www.who.int/lymphatic_filariasis/elimination-programme/en/.

4. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement;Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations,2012

5. Global programme to eliminate lymphatic filariasis: progress report, 2018;World Health Organization;Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The lymphatic filariasis treatment study landscape: A systematic review of study characteristics and the case for an individual participant data platform;PLOS Neglected Tropical Diseases;2024-01-16

2. Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study;Drug Safety;2023-08-08

3. A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis;PLOS Neglected Tropical Diseases;2023-05-19

4. Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis;PLOS Neglected Tropical Diseases;2022-10-28

5. Adverse drug effects among students following mass de-worming exercise involving administration of Praziquantel and Albendazole in KEEA Municipality, Ghana;PLOS Neglected Tropical Diseases;2022-09-12